News

Dexcom CGM users to have clearer way of understanding trend arrows

29-11-17
A new method allows young people and adults with type 1 diabetes to better understand and make better use of trend arrow data from the Dexcom G5 mobile continuous glucose monitor (CGM) for adapting insulin doses.The Dexcom G5 CGM displays trend arrows indicating whether blood glucose levels are rising or falling, and how fast this is happening. Previously published methods on how best to use this data to adjust insulin doses were deemed imperfect and/or not user-friendly.Two recent studies, conducted by researchers from Harvard .

Calibrating your Dexcom G5 Mobile

21414907_1528898570489302_4129728999868649677_o
Calibrating your Dexcom G5 Mobile twice per day is all that’s required for accurate glucose readings unless prompted by your System. Along with pricking your fingers less often, you’ll be able to use fewer test strips per day!For best results, calibration should be performed while the user is “in-range” between 40 and 400 mg/dL. You should not calibrate during rapid blood glucose rates of change (i.e. single or double arrows up or down). Looking .

Great news!!!

%d1%84%d1%8d%d0%b9%d1%81%d0%b1%d1%83%d0%ba-1-09-17

We’ve added Dexcom G5 Mobile App compatibility as well as support for the Dexcom CLARITY App to the following Android smart devices:

• Samsung Galaxy S8 
• Samsung Galaxy S8 Plus
• LG G6

The Dexcom G5 Mobile App for Android is available for download from the Google Play Store here: http://bit.ly/AndroidDexcomG5MobileApp

We will continue to assess possible support for new phones on an ongoing basis. Please stay tuned for future updates!

You can find a full list of currently compatible smart devices here: http://www.dexcom.com/compatibility

 

The wait is over! The Dexcom G5 Mobile App is now available on #Android* !!!

The wait is over! The Dexcom G5 Mobile App is now available on #Android* and can currently be downloaded for free from the Google Play store here: bit.ly/AndroidDexcomG5MobileApp

*To view a list of compatible Android devices, visit www.dexcom.com/compatibility.

We’ve also put together some helpful FAQs that may answer your basic questions here: www.dexcom.com/faq/android

Important Safety Information: www.dexcom.com/safety-information

 

 
 
 
Dexcom G5 Mobile Now Available on Android Devices!

Expecting The Remarkable At Dexcom

%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d0%b8-%d0%b4%d0%b5%d0%ba%d1%81%d0%ba%d0%be%d0%bc-22-05

“They strive for remarkable. They want awesome. And their recipe for success is a relentless focus on providing solutions for the specific problems faced by diabetics.” – Hal Gregersen and Jeff Dyer, Forbes Contributors

Expecting The Remarkable At Dexcom

The speaker, Kevin Sayer, is President and CEO of Dexcom, Inc. ranked #2 on this year’s Forbes list of Most Innovative Growth Companies (Last year, Dexcom ranked number four.)  Sayer, was describing his interaction with some engineering colleagues who were proposing a next-generation product for diabetes patients. Dexcom, a medical device maker based in San Diego, specializes in continuous glucose monitoring solutions.  Its G5 Mobile CGM System was a breakthrough when it was launched in 2015, as the first system allowing patients — even young children—to use a smart device to keep track of their glucose levels in real time. That innovative device built on earlier innovations that all began with the development of implantable, long-performing glucose sensors the body would not reject.

IS YOUR CGM A GAME CHANGER?

A recent study showed an average A1C reduction of about 1.0% for those using Dexcom. For most of us living with T1D, that’s huge! CGM also contributes to fewer highs and lows. How has your CGM impacted your care? Let us know in the comments!

 
 
   

Can a CGM do more than lower my A1C?

A new study published by Dexcom would say, “yes” and more.

The 24-week trial looked at how effective CGMs are at controlling blood sugar levels and found a wide-range of benefits in Type 1 diabetes management that included but was not limited to lowering A1Cs.

Conducted in 24 different endocrinology practices in the US, the study involved 158 randomized adults with the average age of 48 and who had A1C levels of 7.5% to 9.9%.

By the end of the study, participants saw a reduction in A1C levels by 1.0% and nearly a quarter of participants in the CGM group had an A1C of less than 7.0%. It proves that using a CGM helps in better glycemic control.

“We were hopeful that we would see that,” says David Price, MD, Dexcom’s VP of Medical Affairs, who helped conduct the study.

In part, this could be because of the additional information you receive. Compared to testing BGLs with a meter several times a day, a CGM gives you readings every 5 minutes and trending information with high and low BGL alerts.

The clinical trial is also unique in that it included individuals who were not on insulin pumps. Participants had previously been on multiple daily injections (MDIs) and were given a Dexcom G4 Platinum CGM System. The majority of adults with Type 1 diabetes use insulin injections, but have not been in studies that look at the effectiveness of adding a CGM to care. Results of the study may paint a more accurate picture of management benefits for the larger population.

Dexcom

Jake Leach, our senior vice president of research and development, sat down with Wareable to discuss wearable technology for people with diabetes. Read the article here:

(Important Safety Information: https://www.dexcom.com/safety-information)

%d0%bd%d0%be%d0%b2%d0%be%d1%81%d1%82%d1%8c-31-03-17

How wearable tech is bringing normality to the lives of diabetics